Press release from Companies

Publicerat: 2023-01-20 09:00:52

Redsense Medical AB: Redsense Medical reinforces the team with a new CFO

Redsense Medical announces that Jennie Kardell has been appointed as the company’s new Chief Financial Officer and will join the company in March 2023.

"Redsense is a fascinating company with valuable products and an admirable goal to increase patient safety. I am very excited to be part of this growth journey and contribute taking the company to the next level", says Jennie Kardell.

"I am very happy to welcome Jennie and look forward to working with her. With her extensive financial expertise and solid experience developing processes, I am convinced that she will be an excellent addition to our team", says Pontus Nobréus, CEO of Redsense Medical AB.

About Jennie Kardell

Jennie Kardell, born in 1983, has held leading positions developing both internal and customer’s accounting operations for more than 12 years. She was a partner at Öresunds Redovisning AB up to the acquisition by Ludvig&Co in 2021 and thereafter leading the integration as Office Manager. For customers she has taken on projects ranging from accounting consultant to interim CFO, and from assisting international companies to establish in Sweden, to creating and optimizing processes, preparing for stock market listing and M&A.

Jennie Kardell holds a Bachelor in Economics from Uppsala University and is an SRF Certified Accounting Consultant. In addition, she is current President of SRF Konsulterna, Södra Kretsen and is part of the management team for financial and accounting consulting education at IHM Business School in Malmö, Sweden.

Contact information

For more information, please contact: 
Pontus Nobréus, CEO
Telephone: +46 72-171 1264
E-mail: 
pontus.nobreus (at) redsensemedical.com

Redsense Medical AB (publ), 556646-4862

ABOUT REDSENSE MEDICAL

Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medicalsolves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.

Läs mer hos Cision
Läs mer om Redsense Medical AB